FDA & Prescription Drugs

• Celebrex: Not A Safe Alternative For Some

  M. Brandon Smith | March 02, 2006 1:56 PM | 0 CommentsAtlanta, GA

  After Vioxx was removed from the market in 2004, many former Vioxx users started taking Celebrex as a safer alternative for arthritis pain. A recent study from the Medical Research Institute of New Zealand has shown that Celebrex may not be as safe as once thought when compared with other arthritis treatments. Institute Director Richard Beasley noted: "These findings are critical as the risk is...

• Time Limits For Next Vioxx Trial Set

  M. Brandon Smith | March 01, 2006 12:08 PM | 0 CommentsAtlanta, GA

  The next Vioxx trial, which will begin on March 6, 2006, will be on an entirely new time frame from any other one before it. Manually operated clocks, like those used in a chess game, will be utilized by both sides in order facilitate the pace of the trial. Lawyer's for the Plaintiffs will have 40 hours to present their case, not including opening and closing statements. Counsel for the...

• NeutroSpec Warning Leads to Recall

  Richard Schlueter | December 20, 2005 12:00 PM | 0 CommentsAtlanta, GA

  On December 19th the FDA identified that serious safety concerns exist with a drug administered to patients for diagnostic imaging. This drug has been approved for marketing only since June 2004 and is administered intravenously. The drug is used to detect appendicitis in patients five years of age and older. The drug Neutrospec is manufactured by Palatin Technologies. The FDA received...

• Bextra Lawsuits Mounting

  Richard Schlueter | December 13, 2005 3:53 PM | 0 CommentsAtlanta, GA

  Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (Ten) are commonly associated with an accute drug reaction. Bextra is known to be a risk factor. Despite the drug having been pulled from the market, many patients or representatives of the patients have sought legal help in prosecuting legal claims.The likely delay of many to understand the causal link and ability to make a claim...

• Vioxx Lawsuit Ends In Mistrial

  Richard Schlueter | December 13, 2005 3:30 PM | 0 CommentsAtlanta, GA

  In the first Federal Vioxx trial, a Houston judge was forced to declare a mistrial when the jury decided they would not be able to reach a unanimous verdict. According to abcnews.com, eight jurors decided it was not Merck's (the maker of Vioxx) fault that Richard Irvin, Jr. died after taking the drug for less than a month to treat his back pain. However, according to the article,one juror, who...